JP Morgan Maintains Neutral on Teladoc Health, Lowers Price Target to $7

Benzinga Newsdesk www.benzinga.com Negative 77.9%

Neg 77.9% Neu 0% Pos 0%

JP Morgan analyst Lisa Gill maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $9 to $7.